J&J COVID-19 Vaccine Wins Backing of FDA Panel
- WebMD
Feb. 26, 2021 -- A panel of federal advisers on Friday lent their support to authorization for Janssen/Johnson & Johnson’s COVID-19 vaccine.
The FDA is expected to quickly provide an emergency use authorization for the vaccine following the panel’s recommendation. That could happen as early as this evening.
The Vaccines and Related Biological Products Advisory Committee voted 22-0 on this question: Based on the totality of scientific evidence available, do the benefits of the Janssen COVID-19 vaccine outweigh its risks for use in individuals 18 years of age and older?
The Johnson & Johnson vaccine only requires one dose, unlike the two-dose vaccines from Moderna and Pfizer. And unlike those two, the Johnson & Johnson vaccine may be stored at regular refrigerator temperatures.
It can be stored for at least 3 months at normal refrigerator temperatures of 2° C to 8°C (36°F to 46°F).
More in category
April 18, 2021The NY Times
Colorado health officials warn of a new surge as counties loosen virus restrictions.
April 18, 2021MSN
‘I Noticed a Purple Blister on My Hand. Weeks Later, I Developed Sepsis and Lost My Feet’
April 18, 2021The NY Times
Fauci says he expects a decision on whether the U.S. can resume using Johnson & Johnson’s vaccine on Friday.
April 17, 2021MSN
The number of children who accidentally ingested THC edibles increased 29 times since 2010: report
April 17, 2021The NY Times
Virus cases and hospitalizations rise sharply in Pennsylvania, and dozens of other states see high caseloads.
April 17, 2021The NY Times
The Biden Administration Ends Limits on the Use of Fetal Tissue for Research
